in

FDA’s Kevin Fu on Threat Modeling for Medical Devices

This Data Breach alert was published at 09.04.2021 20.19 on Data Breach Today.

More precise and pervasive cybersecurity threat modeling during manufacturers’ development of medical devices – and also during the regulatory product review process – is critical for risk mitigation, says Kevin Fu, new acting director of medical device cybersecurity at the FDA.

Read the rest of this article here. 

Fraudsters Flooding Collaboration Tools With Malware

Implementing Cybersecurity Best Practices